Skip to main content

Table 2 Multivariate regression analysis of factors associated with HCV antiviral therapy

From: Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

  Adjusted OR (95% CI) P-value
Age 0.969 (0.934, 1.005) 0.0892
Gender   
 Female 1 -
 Male 0.805 (0.346, 1.872) 0.6138
Race   
 White, non Hispanic 1 -
 African-American, non Hispanic 1.019 (0.399, 2.603) 0.3692
 Hispanic 1.882 (0.671, 5.28) 0.3924
 Other 1.93 (0.515, 7.237) 0.4715
Region   
 Northeast 1 -
 Midwest 1.734 (0.368, 8.172) 0.6205
 West 0.920 (0.269, 3.144) 0.438
 South 1.857 (0.686, 5.026) 0.277
Insurance   
 Private Insurance 1 -
 Medicare 3.373 (0.665, 17.097) 0.1527
 Medicaid 2.257 (0.481, 10.592) 0.5098
 Other/unknown 1.300 (0.204, 8.276) 0.4562
 Self-pay 2.440 (0.559, 10.644) 0.4657
 No Charge 1.903 (0.494, 7.335) 0.9823
Depression 0.265 (0.131, 0.536) 0.0002
HIV/HCV Coinfection vs. HCV Monoinfection   
 2005-2006 (year of visit) 0.5145 (0.148, 1.789) 0.296
 2007-2008 (year of visit) 0.3082 (0.014, 6.943) 0.4589
 2009-2010 (year of visit) 0.3293 (0.039, 2.786) 0.3079